Edition:
United Kingdom

Valneva SE (VLS.PA)

VLS.PA on Paris Stock Exchange

3.21EUR
20 Nov 2018
Change (% chg)

-- (--)
Prev Close
€3.21
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
86,784
52-wk High
€4.19
52-wk Low
€2.72

Select another date:

Mon, Nov 19 2018

Emergent-Valneva Zika vaccine clears early trial

A vaccine to prevent infections caused by the deadly mosquito-borne Zika virus induced immune response and was found to be safe in an early stage trial, Emergent BioSolutions Inc and partner Valneva SE said on Monday.

Emergent-Valneva Zika vaccine clears early trial

Nov 19 A vaccine to prevent infections caused by the deadly mosquito-borne Zika virus induced immune response and was found to be safe in an early stage trial, Emergent BioSolutions Inc and partner Valneva SE said on Monday.

Select another date: